Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115


The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.

Lee JH, Kim TI, Jeon SM, Hong SP, Cheon JH, Kim WH.

Int J Cancer. 2012 Aug 1;131(3):752-9. doi: 10.1002/ijc.26421. Epub 2011 Oct 20.


[The effect of metformin on responses to chemotherapy and survival in stage IV colorectal cancer with diabetes].

Lee DJ, Kim B, Lee JH, Park SJ, Hong SP, Cheon JH, Kim TI, Kim WH.

Korean J Gastroenterol. 2012 Dec;60(6):355-61. Korean.


Diabetes, metformin use, and colorectal cancer survival in postmenopausal women.

Cossor FI, Adams-Campbell LL, Chlebowski RT, Gunter MJ, Johnson K, Martell RE, McTiernan A, Simon MS, Rohan T, Wallace RB, Paulus JK.

Cancer Epidemiol. 2013 Oct;37(5):742-9. doi: 10.1016/j.canep.2013.04.015. Epub 2013 Jun 15.


Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?

Zanders MM, van Herk-Sukel MP, Vissers PA, Herings RM, Haak HR, van de Poll-Franse LV.

Br J Cancer. 2015 Jul 28;113(3):403-10. doi: 10.1038/bjc.2015.259. Epub 2015 Jul 16.


Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.

Lee JH, Jeon SM, Hong SP, Cheon JH, Kim TI, Kim WH.

Dig Liver Dis. 2012 Dec;44(12):1042-7. doi: 10.1016/j.dld.2012.06.007. Epub 2012 Jul 11.


Metformin use and survival after colorectal cancer: A population-based cohort study.

Mc Menamin ÚC, Murray LJ, Hughes CM, Cardwell CR.

Int J Cancer. 2016 Jan 15;138(2):369-79. doi: 10.1002/ijc.29720. Epub 2015 Aug 31.


Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.

Garrett CR, Hassabo HM, Bhadkamkar NA, Wen S, Baladandayuthapani V, Kee BK, Eng C, Hassan MM.

Br J Cancer. 2012 Apr 10;106(8):1374-8. doi: 10.1038/bjc.2012.71. Epub 2012 Mar 15.


Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.

Rieken M, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Faison T, Lotan Y, Karakiewicz PI, Sun M, Fajkovic H, Babjuk M, Bachmann A, Scherr DS, Shariat SF.

Urol Oncol. 2014 Jan;32(1):49.e7-14. doi: 10.1016/j.urolonc.2013.07.006. Epub 2013 Oct 17.


Effects of metformin on CD133+ colorectal cancer cells in diabetic patients.

Zhang Y, Guan M, Zheng Z, Zhang Q, Gao F, Xue Y.

PLoS One. 2013 Nov 21;8(11):e81264. doi: 10.1371/journal.pone.0081264. eCollection 2013.


Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.

Lee CK, Jung M, Jung I, Heo SJ, Jeong YH, An JY, Kim HI, Cheong JH, Hyung WJ, Noh SH, Kim HS, Rha SY, Chung HC.

Ann Surg. 2016 Jan;263(1):96-102. doi: 10.1097/SLA.0000000000001086.


Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.

Dehal AN, Newton CC, Jacobs EJ, Patel AV, Gapstur SM, Campbell PT.

J Clin Oncol. 2012 Jan 1;30(1):53-9. doi: 10.1200/JCO.2011.38.0303. Epub 2011 Nov 28.


Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.

He XK, Su TT, Si JM, Sun LM.

Medicine (Baltimore). 2016 Feb;95(7):e2749. doi: 10.1097/MD.0000000000002749. Review.


Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.

Sehdev A, Shih YC, Vekhter B, Bissonnette MB, Olopade OI, Polite BN.

Cancer. 2015 Apr 1;121(7):1071-8. doi: 10.1002/cncr.29165. Epub 2014 Nov 25.


Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.

Mei ZB, Zhang ZJ, Liu CY, Liu Y, Cui A, Liang ZL, Wang GH, Cui L.

PLoS One. 2014 Mar 19;9(3):e91818. doi: 10.1371/journal.pone.0091818. eCollection 2014. Review. Erratum in: PLoS One. 2014;9(7):e103652.


Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients.

Bella F, Minicozzi P, Giacomin A, Crocetti E, Federico M, Ponz de Leon M, Fusco M, Tumino R, Mangone L, Giuliani O, Budroni M, Sant M.

J Cancer Res Clin Oncol. 2013 Aug;139(8):1303-10. doi: 10.1007/s00432-013-1439-8. Epub 2013 Apr 30.


The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.

Zhang ZJ, Li S.

Diabetes Obes Metab. 2014 Aug;16(8):707-10. doi: 10.1111/dom.12267. Epub 2014 Feb 27.


Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.

Rieken M, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Faison T, Lotan Y, Karakiewicz PI, Fajkovic H, Babjuk M, Kautzky-Willer A, Bachmann A, Scherr DS, Shariat SF.

BJU Int. 2013 Dec;112(8):1105-12. doi: 10.1111/bju.12448.


Metformin use is associated with better survival of diabetic patients with pancreatic cancer.

Sadeghi N, Abbruzzese JL, Yeung SC, Hassan M, Li D.

Clin Cancer Res. 2012 May 15;18(10):2905-12. doi: 10.1158/1078-0432.CCR-11-2994. Epub 2012 Mar 31.


Use of metformin and survival of diabetic women with breast cancer.

Peeters PJ, Bazelier MT, Vestergaard P, Leufkens HG, Schmidt MK, de Vries F, De Bruin ML.

Curr Drug Saf. 2013 Nov;8(5):357-63.

Items per page

Supplemental Content

Write to the Help Desk